We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Occlusion Caused by Cosmetic Facial Filler Injection—Reply

Michelle Valerie Carle, MD1,2; Richard H. Roe, MD, MHS2; Roger Lawrence Novack, MD, PhD2
[+] Author Affiliations
1Now with EyeQ Vision Care, Fresno, California
2Retina-Vitreous Associates Medical Group, Los Angeles, California
JAMA Ophthalmol. 2015;133(2):225. doi:10.1001/jamaophthalmol.2014.4247.
Text Size: A A A
Published online


In Reply Much literature has been published for several decades regarding injection sites in and around the facial area for cosmetic and medical reasons, which can result in vision loss or worse consequences.15 The glabella has been reported several times and is in close proximity to the main arterial supplies, the supratrochlear and supraorbital arteries, which, as Kim and colleagues correctly identified, are the likely arteries inadvertently cannulated during the procedure. Our series, however, was focused on purely higher forehead injection, which, owing to the more distal location, may provide a false sense of security to physicians doing the injection as the branched arteries are smaller in these regions. We wanted to ensure that “forehead” was cited as a distinct entity, not “roughly described” and included in the glabellar region.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





February 1, 2015
Yong-Kyu Kim, MD; Na-Kyung Ryoo, MD; Kyu Hyung Park, MD, PhD
1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea2Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea
JAMA Ophthalmol. 2015;133(2):224-225. doi:10.1001/jamaophthalmol.2014.4243.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...